Wentao Zhang, Ph.D.
Dr. Wentao Zhang is the Co-Chief Executive Officer at Frontage Laboratories. In this role, Dr. Zhang is responsible for Frontage’s comprehensive end-to-end services in Global Drug Discovery, DMPK, Safety & Toxicology, CMC and Product Development, in addition to leading Finance, Legal and Human Resources functions.
Previously Dr. Zhang served as the Chief Strategy Officer where he successfully led global restructuring and positioned Frontage for growth. He came to Frontage Laboratories in 2021 through the acquisition of Quintara Discovery, an innovative and highly profitable discovery service organization based in the San Francisco Bay Area, that he founded in 2012. Before founding Quintara, Dr. Zhang was Senior Director at Exelixis where he managed key drug discovery platforms and functions that included compound repository, assay development and high-throughput screening, lead optimization, DMPK and safety pharmacology.
Dr. Zhang received his BS in Chemistry from Peking University, MS in Bioanalytical Chemistry from Emory University and PhD in Biophysical Chemistry from University of Wisconsin-Madison. He did postdoctoral research at the University of California-Berkeley.
